The global Medical Device Contract Manufacturing Market continues to experience explosive growth, with its value rising to USD 69.75 billion in 2023 and projected to reach USD 191.40 billion by 2032. Driven by rising healthcare needs, increased outsourcing from OEMs, and rapid advancements in smart manufacturing technologies, the market is undergoing a profound transformation. As healthcare systems evolve, the demand for precision-engineered medical devices is surging, creating a strong foundation for contract manufacturing companies that offer specialized, scalable, and compliant production solutions.

The forecasted CAGR of 11.89% between 2024 and 2032 reflects the industry’s accelerated shift toward outsourcing to reduce operational costs, optimize production, and meet stringent regulatory standards. The growing complexities of medical devices, particularly Class II and Class III categories, require advanced manufacturing capabilities and robust quality control mechanisms—further boosting the prominence of contract manufacturers in the global supply chain.

OEMs across all major therapeutic areas are increasingly relying on external manufacturing partners to streamline production cycles, speed up time-to-market, and access innovative technologies including automation, robotics, AI-driven quality assurance, and advanced material engineering. As the competitive landscape intensifies, contract manufacturers equipped with regulatory expertise, adaptable production capabilities, and end-to-end service portfolios are emerging as strategic partners for healthcare innovators.

Get free Sample Report@ https://www.snsinsider.com/sample-request/5958

The market’s expansion is further reinforced by increasing demand for high-performance medical accessories, consumables, wearable devices, and drug-device combination products. The rise of home healthcare, telemedicine, and minimally invasive treatments has also contributed to consistent demand growth across various product categories. Contract manufacturers are responding with improved operational agility, flexible device customization, and enhanced capacity to handle production surges across global markets.

Growing Demand for Class II and Class III Devices

In 2023, Class II devices held an impressive 80.8% share of total revenue, emphasizing the dominant role of products such as diagnostic equipment, infusion pumps, and power wheelchairs. These devices often require specialized facilities, sophisticated engineering, and strict compliance frameworks—conditions ideally suited for contract manufacturing firms. Additionally, innovations in wearable diagnostics and home monitoring systems continue to push the boundaries of Class II device development.

Simultaneously, Class III devices—ranging from pacemakers and implantable defibrillators to advanced artificial heart valves—are expected to record the fastest growth over the forecast period. This trend is fueled by the rising prevalence of chronic diseases, aging populations worldwide, and a heightened focus on life-sustaining, high-risk medical technologies. Contract manufacturers with capabilities in precision machining, biocompatible materials, and high-end device assembly are capitalizing on the increasing demand for sophisticated Class III solutions.

Accessories and Device Manufacturing Services Lead the Market

The accessories manufacturing segment led the market with a 47.5% revenue share in 2023. High-volume production of essential components such as tubing, sensors, and connectors remains critical for a wide range of medical devices. The rapid growth of wearable health technology and remote monitoring devices further elevates demand for compact, durable, and high-performance accessories.

Meanwhile, full device manufacturing services are set to grow rapidly as OEMs continue to outsource complete production lines to reduce internal costs and operational complexities. With medical devices becoming increasingly intricate and regulations intensifying globally, contract manufacturers equipped with comprehensive device assembly, testing, sterilization, and packaging solutions are gaining significant momentum.

Cardiovascular and Ophthalmic Therapeutic Areas Strengthen Market Potential

Cardiovascular devices accounted for the largest market share in 2023 at 26.67%, supported by growing cases of cardiac disorders and increased adoption of minimally invasive procedures. Contract manufacturers are playing a key role in advancing stent technologies, implantable cardiac devices, and catheter-based systems as healthcare systems prioritize high-precision, reliable cardiac treatment options.

The ophthalmic devices segment, however, is expected to record the highest growth rate through 2032. Rising incidences of glaucoma, cataracts, and age-related macular degeneration are prompting demand for advanced surgical and diagnostic ophthalmic equipment. Innovations in laser-assisted surgeries, micro-incision devices, and vision correction tools are encouraging manufacturers to expand ophthalmology-focused production capabilities.

OEMs Dominate End-Use Demand

OEMs accounted for 45.5% of the total market share in 2023 as companies increasingly shifted toward outsourcing to reduce costs and focus on R&D. Contract manufacturers provide OEMs with regulatory support, reduced lead times, and streamlined supply chains—factors that are becoming essential in the fast-evolving medical device development landscape.

The pharmaceutical and biopharmaceutical sector is anticipated to show the fastest growth during the forecast period. The rise of drug-device combination products, including auto-injectors, inhalers, and prefilled syringes, is reshaping requirements for precision-engineered delivery systems. As biologics and personalized medicine expand globally, demand for highly specialized manufacturing environments continues to increase.

Asia Pacific Leads Global Growth, While North America Accelerates Innovation

Asia Pacific dominated the Medical Device Contract Manufacturing Market in 2023, capturing 38.7% of total revenue. The region’s cost-efficient production ecosystem, skilled technical workforce, and increasingly supportive government policies have positioned it as a global manufacturing hub. Countries such as China, India, and Malaysia are witnessing rapid industrial expansion with major manufacturers investing in large-scale production facilities.

North America, on the other hand, is projected to be the fastest-growing region over the coming decade. The U.S. and Canada continue to attract major OEMs seeking advanced manufacturing capabilities, strong regulatory compliance systems, and early access to cutting-edge technological innovations. Growth in robotic-assisted surgeries, AI-enabled diagnostics, and smart medical systems is further driving investment in sophisticated contract manufacturing solutions.

Competitive Landscape Strengthens with Capacities and Strategic Investments

The market features several globally recognized players, including Jabil Inc., Thermo Fisher Scientific Inc., Integer Holdings Corporation, FLEX LTD., Sanmina Corporation, Celestica Inc., Phillips-Medisize, Plexus Corp., Nipro Corporation, Viant Technology LLC, West Pharmaceutical Services Inc., Mack Molding, Cirtec Medical, Cogmedix, Synecco Ltd., TE Connectivity, Keller Technology Corp., and HDA Technology Inc. These companies are engaged in strategic expansions, acquisitions, and technological innovations to enhance production capacity and address evolving OEM requirements.

Growing emphasis on automation, digital manufacturing, and sustainable production is reshaping the competitive dynamics. Manufacturers are increasingly incorporating IoT-enabled monitoring, AI-driven quality assessments, and eco-friendly materials into their production lines to meet next-generation market expectations.

Buy Full Report Now: https://www.snsinsider.com/checkout/5958

FAQ

1. What is driving the rapid growth of the Medical Device Contract Manufacturing Market?

The primary drivers include rising outsourcing by OEMs, increasing complexity of medical devices, stringent regulatory requirements, and continuous technological advancements in manufacturing processes.

2. Which product segment currently dominates the market?

Class II devices dominate with an 80.8% share due to high outsourcing rates for diagnostic equipment, infusion pumps, and similar devices requiring specialized production capabilities.

3. Which region leads the global market?

Asia Pacific leads the market due to its cost-efficient manufacturing base, skilled labor, and growing medical device demand driven by aging populations and chronic disease prevalence.

4. Why are pharmaceutical companies increasing reliance on contract manufacturers?

The growing demand for drug-device combination products such as auto-injectors and inhalers requires specialized manufacturing expertise, prompting pharmaceutical companies to outsource production.

5. What growth rate is expected for the Medical Device Contract Manufacturing Market through 2032?

The market is expected to grow at a CAGR of 11.89% from 2024 to 2032, reaching USD 191.40 billion by the end of the forecast period.

Other Trending Reports

Prenatal Care Market

Artificial Intelligence in Ultrasound Imaging Market

Thyroid Cancer Diagnostics Market

Endoscopes Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Rohan Jadhav - Principal Consultant

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Email: info@snsinsider.com